News

We would like to announce that we have officially partnered with Cambridge NeuroTech to expand our reach and enhance our distribution network. This collaboration marks a significant milestone for both companies and promises to bring cutting-edge technologies to even more people around the globe.Cambridge NeuroTech will now handle ALL product sales. Moving forward, our 64-channel, 128-channel, Janus Double-sided probes, and Deep Array will now be distributed through Cambridge NeuroTech. This new partnership allows for us to focus on emerging neurotechology which we feel are our top priority to...

GLEN BURNIE // January 31, 2024 - Diagnostic Biochips is pleased to announce the appointment of Allen Waziri, MD, Co-Founder and CEO of iCE Neurosystems, to its Board of Directors.

Diagnostic Biochips’ Brian G. Jamieson PhD co-authored “Multichannel Silicon Probes for Awake Hippocampal Recordings in Large Animals” with Alexandra V. Ulyanova, Carlo Cottone, Christopher D. Adam, Kimberly G. Gagnon, D. Kacy Cullen, Tahl Holtzman, Paul F. Koch, H. Isaac Chen, Victoria E. Johnson, and John A. Wolf. The research article was published in the Neural Technology section of Frontiers in Neuroscience on April 26, 2019.

Diagnostic BioChips was awarded a $1.8M grant to further develop its technology for continuous in vivo monitoring of IL-6 for the early detection of sepsis or cytokine storm syndrome.

TEDCO (Technology Development Corporation of MD) has awarded DBC a grant to support the cost of regulatory consulting for preparing our first FDA submission for the continuous monitoring of doxorubicin in the bloodstream of chemotherapy patients.